3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow AIDS-related Diffuse Mixed Cell Lymphoma: new trials by email Literature Review of AIDS-related Diffuse Mixed Cell Lymphoma trials Research Report on AIDS-related Diffuse Mixed Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors gamma-secretase/Notch signalling pathway inhibitor RO4929097, capecitabine, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2010-06-01 | 2014-11-07 |
| Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy sunitinib malate, pharmacological study, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Phase 1 | Completed | National Cancer Institute (NCI) | 42 | 2009-08-01 | 2014-03-17 |
| Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma bryostatin 1, vincristine sulfate - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 12 | 2001-11-01 | 2013-01-25 |
Burkitt Lymphoma (2) · Hodgkin Disease (2) · Immunoblastic Lymphadenopathy (2) · Intraocular Lymphoma (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Extranodal NK-T-Cell (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Anaplastic (2) · Lymphoma, Large-Cell, Immunoblastic (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma, T-Cell, Cutaneous (2) · Mycosis Fungoides (2)
Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Chronic Disease (2) · DNA Virus Infections (2) · Disease Attributes (2) · Epstein-Barr Virus Infections (2) · Eye Neoplasms (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Herpesviridae Infections (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Infections (2)
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · Bryostatins (1) · Capecitabine (1) · Sunitinib (1) · Vincristine (1) · bryostatin 1 (1)
National Cancer Institute (NCI) (3)
United States (3) · Canada (1)
John Deeken (1) · Noelle LoConte (1) · Scot Remick (1)
P30CA014520 (1), U01CA062491 (1), U01CA070019 (1), U01CA121947 (1), U01CA132123 (1)